Research and Development

Holistic Hope promotes research and development of sustainable, environmentally responsible cannabis cultivation, and of beneficial products derived from the cannabis plant. Holistic Hope promotes medical research of cannabis by encouraging studies of the cannabis plant, (its active ingredients, its physiological, pharmacological, and chemical effects), and the advantages of its use and possible risks.

Cannabis research involves different disciplines, such as biology, botany, chemistry, biochemistry and agronomy. There is great importance in the collaboration of academia with government and the private sector in this field.

Cannabis research began in Israel in the 1960s with Prof. Raphael Mechoulam’s groundbreaking research and the detection of THC and CBD, along with the discovery of cannabis receptors in the human body, and of the endocannabinoidsystem.

Nowadays, the world has various entities conducting research in the medical cannabis field, from top universities to private companies and even governmental institutes. Teams are looking into the effects of cannabis in a wide range of areas, including cancer, PTSD, autism, epilepsy, Crohn’s disease and schizophrenia. At the time of writing, tens of active clinical trials are being conducted in Israel. As Israel is considered an attractive location for clinical trials in a number of medical fields, and medical cannabis is no exception.

To date, more than 15,000 modern peer-reviewed scientific articles on the chemistry and pharmacology of cannabis and cannabinoids have been published, as well as more than 2,000 articles on the body’s natural endocannabinoids. In recent years, more placebo-controlled human trials have also been conducted.

Holistic Hope believes believes in innovation and our strategic partners operate in a range of research disciplines and thrive thanks to the combination of human resources, the academic environment, and governmental support of companies.